logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Joanne M. Langley

Hospital Universitario La Paz

64H-index
412Paper Count
1.4WCitation Count
Published Papers 128
Publication Date
logo
Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study
errHuman Vaccines & Immunotherapeutics
IF0
err2026-05-23
err0
PREAI
errLeroux-Roels, Isabel; De Coster, Ilse; Borobia, Alberto M.; Langley, Joanne M.; Ochoa Mazarro, Dolores; Ruiz-Antoran, Belen; Berre, Stefano; Germain, Sophie; Knauer, Christine; Koch, Sven D.; Mann, Philipp; Mesia Vela, Doris; Ovbude, Leroy Jide; Pardo, Iris Alessandra; Srivastava, Barkha; Moldt, Brian; Nordgren, Marcus
errShare
errSave
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
errHuman Vaccines & Immunotherapeutics
IF0
err2026-05-23
err1
PREAI
errFitzpatrick, Tiffany; Parsons Leigh, Jeanna; Brundin-Mather, Rebecca; MacDonald, Jade; Blanchard, Wade; Bolotin, Shelly; Buchan, Sarah A.; Brousseau, Nicholas; Castillo, Eliana; Comeau, Jeannette L.; Dube, Eve; Greyson, Devon; Halperin, Scott A.; Langley, Joanne M.; Lee, Janet S. W.; MacDonald, Shannon E.; Manca, Terra; Moss, Stephana Julia; Papenburg, Jesse; Vadlamudi, Nirma Khatri; Halperin, Donna
errShare
errSave
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans
errNature Immunology
IF27.6
err2026-03-19
err0
errOAAI
errSurender Khurana; Olivia Posadas; Lela Kardava; Elizabeth M. Coyle; Supriya Ravichandran; Gabrielle Grubbs; Rosemary McConnell; Nadine Rouphael; Guillaume Poliquin; Joanne M. Langley; Eric Chu; Dean A. Follmann; Xiaoran Shang; Yuxing Li; Susan Moir; Richard T. Davey
errShare
errSave
Healthcare costs and resource utilization for acute respiratory syncytial virus pediatric hospitalizations in Canada: a population-based study
errThe Lancet Regional Health - Americas
IF0
err2025-10-06
err0
errOAAI
errNirma Khatri Vadlamudi; Kyle Gomes; Ethan Chow; Malou Bourdeau; Joanne Embree; Scott A. Halperin; Taj Jadavji; Kescha Kazmi; Joanne M. Langley; Nicole Le Saux; Dorothy Moore; Shaun K. Morris; Jeffrey M. Pernica; Joan Robinson; Manish Sadarangani; Julie A. Bettinger
errShare
errSave
Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the Americas
errVaccines 2025, Vol. 13, Page 974
IF3.4
err2025-09-29
err0
errOAAI
errGaurav Mathur; Joseph B. Domachowske; Maria Gabriela Graña; Reena Ladak; Joanne M. Langley; Oluwatosin Olaiya; Alysa Pompeo; Laura Taddei; Rodolfo Villena
errShare
errSave
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial
errVaccine
IF3.5
err2025-09-16
err0
PREAI
errGlenn Hamonic; Elodie Pastural; Supriya Arora; Jocelyne Lew; Yun Cai; Erin Scruten; Rachelle Buchanan; May ElSherif; Lingyun Ye; Thomas Courant; Roland A. Ventura; Nicolas Collin; Matthieu Daugan; Luc Gagnon; Paul Hodgson; Sylvia van Drunen Little-van den Hurk; Darryl Falzarano; Steve Sanche; Scott A. Halperin; Joanne M. Langley; Volker Gerdts; Trina Racine
errShare
errSave
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023
errEPIDEMIOLOGY & INFECTION
IF2.2
err2025-06-23
err1
errOAAI
errColeman, Brenda L.; Robertson, Nicole M.; Harrison, Robyn A.; Valiquette, Louis; Langley, Joanne M.; Muller, Matthew P.; Cooper, Curtis L.; Nadarajah, Jeya; Powis, Jeff; Arnoldo, Saranya; Smieja, Marek; Vanderkooi, Otto G.; Qi, Freda; Colwill, Karen; Gingras, Anne Claude; McGeer, Allison
errShare
errSave
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial
errThe Lancet Respiratory Medicine
IF0
err2025-04-14
err0
PREAI
errMichael G Ison; Alberto Papi; Eugene Athan; Robert G Feldman; Joanne M Langley; Dong-Gun Lee; Isabel Leroux-Roels; Federico Martinon-Torres; Tino F Schwarz; Richard N van Zyl-Smit; Susanna Cuadripani; Quentin Deraedt; Nancy Dezutter; Catherine Gerard; Laurence Fissette; Stebin Xavier; Marie-Pierre David; Aurélie Olivier; Marie Van der Wielen; Dominique Descamps; Manuel Zocco
errShare
errSave
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
errBMC INFECTIOUS DISEASES
IF3
err2025-02-13
err0
errOAAI
errSumsuzzman, Dewan Md.; Ye, Yang; Wang, Zhen; Pandey, Abhishek; Langley, Joanne M.; Galvani, Alison P.; Moghadas, Seyed M.
errShare
errSave
Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2025-01-29
err0
PREAI
errBanooni, Peyman; Gonik, Bernard; Epalza, Cristina; Reyes, Osvaldo; Madhi, Shabir A.; Gomez-Go, Grace Devota; Zaman, Khalequ; Llapur, Conrado Juan; Lopez-Medina, Eduardo; Stanley, Thorsten; Kantele, Anu; Huang, Li-Min; Mussi-Pinhata, Marisa Marcia; Dewulf, Jonas; Langley, Joanne M.; Seidl, Claudia; Ota, Martin; Kirabo, Martha; Anspach, Bruno; Dieussaert, Ilse; Henry, Ouzama; Kim, Joon Hyung; Picciolato, Marta; InvestiGational RSV mAternal vacCinE GRACE Study Grp
errShare
errSave
Respiratory syncytial virus vaccination during pregnancy
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-11-24
err0
errOAAI
errAbu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal
errShare
errSave
Nirsevimab to reduce childhood morbidity caused by respiratory syncytial virus
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-11-24
err0
errOAAI
errAbu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal
errShare
errSave
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2024-10-30
err0
errOAAI
errNolan, Terry; Bhusal, Chiranjiwi; Beran, Jiri; Bloch, Mark; Cetin, Benhur S.; Dinleyici, Ener C.; Drazan, Daniel; Kokko, Satu; Koski, Susanna; Laajalahti, Outi; Langley, Joanne M.; Ramet, Mika; Richmond, Peter C.; Silas, Peter; Tapiero, Bruce; Tiong, Florence; Tipton, Mary; Ukkonen, Benita; Ulukol, Betul; Lattanzi, Maria; Trapani, Mauro; Willemsen, Arnold; Toneatto, Daniela
errShare
errSave
Nirsevimab to reduce infant morbidity from respiratory syncytial virus
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-09-30
err2
errOAAI
errAbu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal
errShare
errSave
Respiratory syncytial virus vaccination in pregnancy
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-09-30
err2
errOAAI
errAbu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal
errShare
errSave
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2024-08-08
err1
errOAAI
errLangley, Joanne M.; Nolan, Terry M.; Ramet, Mika; Richmond, Peter C.; Rosario Filho, Nelson; Haazen, Wouter; van den Berg, Sara P. H.; Williams, Kristi; Bastian, Arangassery Rosemary; Omoruyi, Edmund; Durkin, Joanna Williams; Salisch, Nadine; Van Geet, Gunter; van Duijnhoven, Wilbert; Heijnen, Esther; Callendret, Benoit
errShare
errSave
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-01-22
err50
errOAAI
errIson, Michael G.; Papi, Alberto; Athan, Eugene; Feldman, Robert G.; Langley, Joanne M.; Lee, Dong-Gun; Leroux-Roels, Isabel; Martinon-Torres, Federico; Schwarz, Tino F.; van Zyl-Smit, Richard N.; Verheust, Celine; Dezutter, Nancy; Gruselle, Olivier; Fissette, Laurence; David, Marie-Pierre; Kostanyan, Lusine; Hulstrom, Veronica; Olivier, Aurelie; van der Wielen, Marie; Descamps, Dominique
errShare
errSave
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study
errLANCET REGIONAL HEALTH-AMERICAS
IF7.6
err2023-12-01
err24
errOAAI
errShoukat, Affan; Abdollahi, Elaheh; Galvani, Alison P.; Halperin, Scott A.; Langley, Joanne M.; Moghadas, Seyed M.
errShare
errSave
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2023-11-30
err21
errOAAI
errMoghadas, Seyed M.; Shoukat, Affan; Bawden, Carolyn E.; Langley, Joanne M.; Singer, Burton H.; Fitzpatrick, Meagan C.; Galvani, Alison P.
errShare
errSave
PreHevbrio: the first approved 3-antigen hepatitis B vaccine
errEXPERT REVIEW OF VACCINES
IF4.8
err2023-11-06
err5
errOAAI
errVesikari, Timo; Langley, Joanne M.; Popovic, Vlad; Diaz-Mitoma, Francisco
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
Didier Raoult
H-index: 198 · Papers: 4.0K
A
Anne‐Claude Gingras
H-index: 114 · Papers: 632
A
Andrew J. Pollard
H-index: 114 · Papers: 1.2K
A
Allison McGeer
H-index: 113 · Papers: 1.1K
A
Alberto Papi
H-index: 110 · Papers: 1.0K
View more